個股熱度排行 | 8月19日港股盤前
根據uSMART輿情監測數據,從18日晚間到19日港股盤前時間段,市場關注指數最高的5只股票是騰訊控股、越秀地產、名創優品、藥明生物、貓眼娛樂。
8月19日—港股關注排行TOP5

騰訊控股

關注度第一爲騰訊控股,該股上個交易日收盤上漲3.10%,報於312.60港元。近5個交易日累計上漲2.96%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
騰訊管理層詳解幾大核心業務:營收見頂後 騰訊路在何方?
騰訊幻核宣佈停售背後,數藏平臺這些風險不可不知
越秀地產

關注度第二爲越秀地產,該股上個交易日收盤下跌2.42%,報於9.26港元。近5個交易日累計下跌0.75%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
越秀地產發佈上半年業績 營業收入同比增加29.12%至312.93億元
TOD項目支撐銷售增長 越秀地產還要花457億元拿地
名創優品

關注度第三爲名創優品,該股上個交易日收盤下跌4.03%,報於11.44港元。近5個交易日累計下跌4.83%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
不再假裝“日系血統”!名創優品致歉,還定下“去日化”截止日期
名創優品爲“僞日系”道歉:將徹底進行“去日化”整改
藥明生物

關注度第四爲藥明生物,該股上個交易日收盤上漲2.80%,報於71.70港元。近5個交易日累計下跌0.35%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
藥明生物授出合共174.4萬股受限制股份予151名僱員
藥明生物:WuXi XDC向66名WuXi XDC僱員授出合共905.3萬份購股權
貓眼娛樂

關注度第五爲貓眼娛樂,該股上個交易日收盤上漲0.58%,報於6.89港元。近5個交易日累計上漲0.88%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
貓眼娛樂中期經調整淨利約2.34億元 參與的上映電影數量及票房表現均位居行業前列
貓眼娛樂2022年上半年財報發佈:深耕服務打磨精品,總體抗風險能力持續增強
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.